Pancreatic cancer: new hopes for early detection and a future screening tool?

Najla H El-Jurdi, Muhammad Wasif Saif

Research output: Contribution to journalArticlepeer-review

Abstract

Given the overall poor prognosis of patients with pancreatic cancer, there has always been an interest in early screening and primary prevention. An abstract presented in ASCO 2014 by Orlowski et al. introduced the potential use of an elevated serum procarboxypeptidase A (PCPA) and high ratios of PCPA to free carboxypeptidase A (FCPA) in enhancing the diagnostic efficacy of pancreatic cancer either alone or with CA19-9 (Abstract #4118).

Original languageEnglish (US)
Pages (from-to)358-9
Number of pages2
JournalJournal of the Pancreas
Volume15
Issue number4
DOIs
StatePublished - Jul 28 2014

Keywords

  • Biomarkers, Tumor/blood
  • CA-19-9 Antigen/blood
  • Carboxypeptidases A/blood
  • Early Detection of Cancer/methods
  • Forecasting
  • Humans
  • Pancreatic Neoplasms/blood
  • Sensitivity and Specificity

PubMed: MeSH publication types

  • Journal Article

Fingerprint Dive into the research topics of 'Pancreatic cancer: new hopes for early detection and a future screening tool?'. Together they form a unique fingerprint.

Cite this